Cycle Labs Briefing Note
Axendia was briefed by Josh Owen, Founder, President and Executive Chair, at Cycle Labs, an organization focused on addressing a persistent and growing challenge across regulated industries: how to validate change in increasingly complex, interconnected enterprise supply chain systems without introducing unacceptable operational or compliance risk.
Originally developed as a differentiator within a supply-chain consulting firm, the Cycle Labs platform evolved into a standalone SaaS offering designed to unify compliance expectations with operational assurance, enabling organizations to validate not only that systems are governed correctly, but that they will execute reliably at scale.
The Industry Problem: Change Avoidance in a High-Risk Environment
Life sciences manufacturers and distributors rely on large-scale enterprise platforms, such as ERP, warehouse and transportation management systems (WMS, TMS), order management systems (OMS), and manufacturing execution systems (MES), to run mission-critical supply chain operations. While these platforms are foundational to quality, safety, and supply continuity, they are also a source of systemic risk, especially considering enterprise system upgrades often occur only every five to seven years. According to Owen, “The root cause is not a lack of innovation, but a pervasive fear of introducing operational risk. As systems become more tightly coupled and more customized over time, organizations face mounting difficulty validating that changes will perform as intended under real-world operating conditions.”
Over the past two decades, supply chains have undergone a structural transformation. According to Owen, “The rise of e-commerce, omni-channel distribution, automation, robotics, and exponential SKU growth has driven the adoption of increasingly sophisticated execution systems. What were once paper-based or manually coordinated processes are now orchestrated by layers of software, each with its own configurations, integrations, and dependencies. Modern supply chains need a reliable way to validate and simulate change across increasingly complex and interconnected systems.”
As systems complexity rises, so does the difficulty of validating change. Spoken with true candor, Owen states, “Organizations responded by simply avoiding it because they perceived the cost and risk of validation outweighed the incremental value of improvement. That means they are leaving an incredible amount of value on the table.”
As Axendia has reported, this cultural inertia only amplifies the negative impact. Delaying upgrades has a cascading effect, slowing adoption of new capabilities, undermining operational resilience, and interfering with opportunities to improve quality, efficiency, and supply reliability. In effect, significant value remains trapped behind validation bottlenecks. According to Owen, “Supply-chain complexity, velocity, and risk are rising faster than teams can manually test or predict, which has created an urgent need for automated validation and simulation.”
Operational Compliance Requires both Governance and Execution
Life sciences organizations have made substantial investments in governance, risk management, and compliance frameworks. Regulatory expectations clearly require that systems be validated for their intended use, and that documentation demonstrates control, traceability, and accountability.
However, Owen contends that governance alone is insufficient. “While organizations may be able to ‘check the box’ from a compliance standpoint, this does not guarantee that systems will perform as expected once deployed into complex, high-volume production environments.”
Traditional validation approaches remain heavily manual, document-centric, and episodic. Owen captures a real-life example by explaining that “Subject-matter experts are often pulled from operations to execute scripted tests that confirm whether a specific change works in isolation.” Because these methods miss the critical question of whether a single change unintentionally breaks something else, Cycle Labs developed its platform to sit at the intersection of governance and execution.
“By continuously validating end-to-end business processes under realistic operating conditions, organizations gain confidence not only that systems are compliant, but that they are operationally reliable,” explains Owen. This blended approach – combining compliance assurance with operational assurance – addresses a longstanding gap in regulated enterprise environments.
A Vision Anchored in Partnership and Risk-Based Execution
Cycle Labs has built an ecosystem-driven model anchored in partnerships with system integrators and domain specialists who understand how enterprise platforms are deployed and customized in real-world environments. “We can’t pretend to know every industry equally, so we intentionally work with over 20 partners to develop and maintain pre-built test libraries aligned to specific platforms and releases,” states Owen. He goes on to explain that these libraries address about 80 percent or more of standard operations, which also allows companies to focus internal expertise on areas of differentiation and risk.
The Cycle Labs platform supports a three-stage testing process with its customers:
Owen explains, “Rather than treating testing as a one-time project or a purely technical exercise, we frame quality as an ongoing operational capability – one that must evolve alongside the business. And we are confident that this approach sets us apart from our competition.”
In Brief
Life sciences organizations are under increasing pressure to modernize operations while maintaining rigorous compliance and quality standards, yet culture remains an inherent barrier to making these changes.
Cycle Labs offers a differentiated SaaS model that unifies governance and operational assurance, enabling organizations to validate supply chain system changes continuously, at scale, and in alignment with real-world business behaviors. Through a combination of automation, partnership, and risk-based execution, the platform addresses a structural challenge that has constrained innovation across regulated enterprise environments.
We will continue to provide updates on Cycle Labs as they become available.
Related Content:
- FDA CSA Just Removed Your Excuses for Implementing Modern Technology
- Industrial DataOps: The Backbone of AI-Ready Manufacturing Data
- From Paper to Cloud: The Digital Transformation of Validation in Life Sciences
Stay Connected with Axendia!
Stay at the forefront of innovation and technology in life sciences, healthcare, and space-enabled research by connecting with Axendia.
- Follow us on LinkedIn: Join our professional network and stay updated on the latest insights, trends, and case studies. Connect with Axendia on LinkedIn
- Subscribe to Our Updates: Get exclusive insights and thought leadership articles delivered straight to your inbox. Sign up for our newsletter
- Share Your Thoughts: We’d love to hear from you! Contact us to discuss your ideas, challenges, or opportunities. Email Axendia
Let’s drive innovation together!
Ready to unlock new opportunities and drive success? Schedule an Analyst Inquiry
The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.